BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
234 results:

  • 1. Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
    Zeng TM; Jiang TY; Yang G; Cheng Z; Lou C; Wei W; Tao CJ; Hu S; Wang H; Cui XW; Tan YX; Dong LW; Wang HY; Yuan ZG
    Clin Transl Med; 2024 May; 14(5):e1675. PubMed ID: 38689424
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of PRL2 Upregulates pten and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
    Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
    Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
    BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
    Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
    Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
    Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
    Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian cancer
    Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X
    Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
    Pencik J; Philippe C; Schlederer M; Atas E; Pecoraro M; Grund-Gröschke S; Li WJ; Tracz A; Heidegger I; Lagger S; Trachtová K; Oberhuber M; Heitzer E; Aksoy O; Neubauer HA; Wingelhofer B; Orlova A; Witzeneder N; Dillinger T; Redl E; Greiner G; D'Andrea D; Östman JR; Tangermann S; Hermanova I; Schäfer G; Sternberg F; Pohl EE; Sternberg C; Varady A; Horvath J; Stoiber D; Malcolm TI; Turner SD; Parkes EE; Hantusch B; Egger G; Rose-John S; Poli V; Jain S; Armstrong CWD; Hoermann G; Goffin V; Aberger F; Moriggl R; Carracedo A; McKinney C; Kennedy RD; Klocker H; Speicher MR; Tang DG; Moazzami AA; Heery DM; Hacker M; Kenner L
    Mol Cancer; 2023 Aug; 22(1):133. PubMed ID: 37573301
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells.
    Sanchez-Martin A; Sanchon-Sanchez P; Romero MR; Marin JJG; Briz O
    Biomed Pharmacother; 2023 Sep; 165():115209. PubMed ID: 37499450
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. pten deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.
    Jiang TY; Cui XW; Zeng TM; Pan YF; Lin YK; Feng XF; Tan YX; Yuan ZG; Dong LW; Wang HY
    Sci Transl Med; 2023 Jul; 15(704):eadd7464. PubMed ID: 37437018
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
    Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
    Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
    Liao X; Lai J; Lin J; Zhang D
    Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Malic Enzyme 1 as a Novel Anti-Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury.
    Fang X; Zhang J; Li Y; Song Y; Yu Y; Cai Z; Lian F; Yang J; Min J; Wang F
    Adv Sci (Weinh); 2023 May; 10(13):e2205436. PubMed ID: 36840630
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/pten/AKT pathway.
    Fang S; Zheng L; Shen L; Su Y; Ding J; Chen W; Chen X; Chen W; Shu G; Chen M; Zhao Z; Tu J; Ji J
    Eur J Pharmacol; 2023 Feb; 940():175465. PubMed ID: 36566915
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream pten-PI3K/Akt pathway.
    Li X; Yin X; Bao H; Liu C
    Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
    Paskeh MDA; Ghadyani F; Hashemi M; Abbaspour A; Zabolian A; Javanshir S; Razzazan M; Mirzaei S; Entezari M; Goharrizi MASB; Salimimoghadam S; Aref AR; Kalbasi A; Rajabi R; Rashidi M; Taheriazam A; Sethi G
    Pharmacol Res; 2023 Jan; 187():106553. PubMed ID: 36400343
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of
    Bodei L; Raj N; Do RK; Mauguen A; Krebs S; Reidy-Lagunes D; Schöder H
    J Nucl Med; 2023 Apr; 64(4):567-573. PubMed ID: 36396457
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. miR-3682-3p Activated by c-Myc Aggravates the Migration and Stemness in Hepatocellular Carcinoma Cells by Regulating pten/PI3K/AKT/β-Catenin Signaling.
    Zhang Y; Cai H; Wu MH; Zhu DH; Wang XY; Chen ZY; Yang L; Liu P; Liu Z
    Dig Dis; 2023; 41(3):447-457. PubMed ID: 36366818
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. pten regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation.
    Chang TM; Chu PY; Lin HY; Huang KW; Hung WC; Shan YS; Chen LT; Tsai HJ
    J Biomed Sci; 2022 Nov; 29(1):92. PubMed ID: 36336681
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate cancer.
    Feng E; Rydzewski NR; Zhang M; Lundberg A; Bootsma M; Helzer KT; Lang JM; Aggarwal R; Small EJ; Quigley DA; Sjöström M; Zhao SG
    Clin Cancer Res; 2022 Dec; 28(24):5396-5404. PubMed ID: 36260524
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific pten knockout mice.
    Arai N; Miura K; Aizawa K; Sekiya M; Nagayama M; Sakamoto H; Maeda H; Morimoto N; Iwamoto S; Yamamoto H
    Sci Rep; 2022 Sep; 12(1):16206. PubMed ID: 36171333
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.